Stock listing

TPEx:6734 iXensor Co., Ltd. (安盛生) 股價

Follow iXensor Co., Ltd. into a list and get an email when it puts out news.

Share price · TPEX:6734

$4.71 TWD -0.29 (-5.8%)

Close on Nov 20, 2026

Past year -24.6% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$4.64 – $4.98 TWDNov 20, 2026
Volume
59,017 sharesNov 20, 2026
Market cap
$198.1M TWDAt the close on Nov 20, 2026 · price × 42.05M shares outstanding
52-week range
$4.18 – $18.50 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$714,439 TWDMedian day 51,779 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
iXensor Co., Ltd. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:6734 · TWD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$4.71-0.29-5.8%$4.84$4.98$4.6459,017
$5.000.000.0%$5.00$5.26$4.7156,251
$5.00-0.26-4.9%$5.10$5.20$4.9447,402
$5.26-0.04-0.8%$5.15$5.39$5.0950,111
$5.30+0.12+2.3%$5.39$5.39$5.1334,102
$5.18-0.12-2.3%$5.30$5.40$5.1381,689
$5.30+0.20+3.9%$5.10$5.30$5.0535,573
$5.10-0.10-1.9%$5.26$5.47$5.1064,935
$5.20-0.05-1.0%$5.13$5.40$5.0067,001
$5.25-0.12-2.2%$4.99$5.47$4.18354,409
$5.37+0.17+3.3%$5.20$5.47$5.1193,135
$5.20+0.01+0.2%$5.19$5.26$4.9440,170
$5.19-0.08-1.5%$5.27$5.36$4.9555,530
$5.27+0.07+1.3%$5.25$5.27$5.028,140
$5.200.000.0%$5.13$5.20$4.78148,175
$5.20-0.20-3.7%$5.40$5.42$5.1528,742
$5.400.000.0%$5.15$5.41$5.1337,264
$5.40-0.45-7.7%$5.85$5.89$5.25210,007
$5.850.000.0%$5.85$5.85$5.850
$5.85+0.74+14.5%$5.29$6.10$5.29269,501
$5.11-0.09-1.7%$5.20$5.30$4.9625,858
$5.200.000.0%$5.20$5.20$4.9533,470
$5.200.000.0%$5.20$5.20$4.9513,047
$5.20-0.04-0.8%$5.24$5.25$4.9530,238
$5.24-0.18-3.3%$5.16$5.42$4.9850,792
$5.42+0.22+4.2%$5.40$5.45$5.1626,671
$5.20+0.11+2.2%$5.26$5.47$5.1543,365
$5.09-0.51-9.1%$5.60$5.61$5.0973,658
$5.60+0.297+5.6%$5.37$5.78$5.22133,680
$5.303+0.03+0.6%$5.283$5.303$5.0464,245
$5.273+0.188+3.7%$4.987$5.273$4.97752,765
$5.086-0.395-7.2%$5.481$5.629$4.701186,606
$5.481+0.471+9.4%$5.194$5.728$4.98770,940
$5.01-0.04-0.8%$5.26$5.26$5.0142,941
$5.05-0.26-4.9%$5.31$5.31$4.9579,295
$5.31+0.15+2.9%$5.16$5.36$5.0637,501
$5.16-0.04-0.8%$5.20$5.47$5.1649,373
$5.20+0.15+3.0%$5.25$5.56$5.2037,577
$5.05-0.27-5.1%$5.30$5.54$5.0582,412
$5.32-0.30-5.3%$5.62$5.62$5.3054,254
$5.62+0.02+0.4%$5.51$5.70$5.30121,884
$5.60-0.09-1.6%$5.66$5.70$5.5089,754
$5.69-0.23-3.9%$5.92$5.92$5.43135,829
$5.92-0.58-8.9%$6.41$6.69$5.61326,675
$6.50-0.98-13.1%$7.18$7.61$6.38554,279
$7.48+1.38+22.6%$6.14$7.90$5.701,668,254
$6.10+1.08+21.5%$4.99$6.23$4.98701,153
$5.02-0.23-4.4%$5.10$5.26$4.9946,178
$5.25-0.25-4.5%$5.32$5.54$4.95114,993
$5.50-0.10-1.8%$5.75$5.75$5.3037,454
$5.60-0.02-0.4%$5.90$5.90$5.35226,584
$5.62-0.37-6.2%$6.10$6.10$5.6238,602
$5.99-0.06-1.0%$5.76$6.26$5.6164,049
$6.05+0.06+1.0%$5.99$6.24$5.76101,823
$5.99-0.06-1.0%$6.10$6.10$5.9926,714
$6.05-0.25-4.0%$6.30$6.31$5.9922,328
$6.30+0.10+1.6%$6.20$6.31$5.9059,535
$6.20-0.20-3.1%$6.10$6.20$5.9028,821
$6.40-0.09-1.4%$6.10$6.40$6.1010,020
$6.49-0.13-2.0%$6.62$6.62$6.2910,232
$6.62+0.21+3.3%$6.13$6.63$6.1345,173
$6.41+0.03+0.5%$6.08$6.41$6.0811,448

Splits

1 split · TPEX:6734 · every price before a split is adjusted for it

DayRatioWhat
2-for-5Consolidation
Ticker
TPEx:6734
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
TPEx
Currency
TWD

iXensor Co., Ltd. on 6ix

Sector
Health care
Industry
Diagnostics & research services

Valuation

EV/sales 6.9× against a median of 1.5×: 9th lowest of 10 Diagnostics & research services companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$185.5M TWD
P/E
Loss
EV/sales
6.9×
EV/EBITDA
Negative EBITDA
Price/book
23.1×
Gross margin
62.9%
Operating margin
−170.1%
Net margin
−174.7%
Debt to equity
0.9×
Beta
No index for this market yet

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
iXensor Co., Ltd. · TPEX:6734US$6.01MUS$5.63Mn/a6.9×n/a23.1×−174.7%0.9×n/a
Fusion Antibodies PLC · LSE:FABUS$6.96MUS$6.03Mn/a2.2×n/a3.3×−54.4%0.2×n/a
IDL Diagnostics AB · OMXSTO:IDLDXUS$6.83MUS$4.56M4.6×0.8×n/a0.5×25.8%0.1×n/a
Visgeneer, Inc. · TPEX:4197US$6.55MUS$7.99M41.1×1.5×36.6×1.1×2.9%0.5×n/a
Milton Essex S.A. · NEWCONNECT:MTNUS$6.07MUS$6.06Mn/a17,573×n/a0.5×n/a0.0×n/a
Cizzle Biotechnology Holdings PLC · LSE:CIZUS$5.70MUS$5.59Mn/an/an/an/an/an/an/a
AcouSort AB · OMXSTO:ACOUUS$5.69MUS$4.76Mn/a6.1×n/a5.9×−140.8%0.0×n/a
GENinCode PLC · LSE:GENIUS$5.42MUS$2.86Mn/a0.7×n/a2.0×−185.5%0.1×n/a
Nanologica AB · OMXSTO:NICAUS$5.29MUS$8.67M2.9×1.6×n/a0.3×34.9%0.3×n/a
VivoSim Labs, Inc. · NASDAQ:VIVSUS$5.29M−US$2.76Mn/a−20.5×n/a0.7×n/a0.1×1.91
Biomerica, Inc. · NASDAQ:BMRAUS$4.97MUS$2.23Mn/a0.5×n/a1.4×−115.5%0.0×0.71
Median of the othersUS$5.70MUS$5.18M4.6×1.5×36.6×1.1×−54.4%0.1×1.31

Team and board

Officers

OfficerRole
Carson ChenChairman & CEO
Peter FitzgeraldDirector & Chief Medical Advisor

Board

DirectorRole
Carson ChenChairman & CEO
Peter FitzgeraldDirector & Chief Medical Advisor

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue26.9M19.5M20.9M105.2M24.8M15.9M30.0M
Cost of revenue9.98M13.5M19.3M42.6M20.2M11.4M21.0M
Gross profit16.9M6.00M1.60M62.6M4.62M4.50M9.03M
Research and development27.2M26.0M26.2M28.0M47.1M36.1M42.4M
Selling, general and administrative35.4M14.5M19.4M17.6M19.3M24.3M41.1M
Operating income-45.7M-46.1M-63.0M-5.23M-81.5M-80.0M-109.0M
Depreciation and amortization6.00M6.17M5.95M7.13M8.70M10.9M11.9M
EBITDA-39.7M-39.9M-57.1M1.90M-72.8M-69.1M-97.1M
Interest expense1.33M1.32M492.0K150.0K48.0K127.0K177.0K
Income before tax-47.0M-46.8M-63.2M-4.89M-73.1M-76.6M-104.7M
Net income-47.0M-46.8M-63.2M-4.89M-73.1M-76.6M-104.7M
Earnings per share, basic-1.16-2.05-1.15-0.09-1.40-1.55-2.15

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents38.3M37.1M47.4M46.2M13.8M34.8M66.3M
Short-term investments2.28M1.90M1.57M1.60M1.60M5.90M30.6M
Receivables190.0K1.59M2.28M1.87M6.63M3.47M8.10M
Inventory9.01M9.55M12.2M20.2M26.6M18.4M25.0M
Current assets54.6M53.9M69.3M75.7M56.7M69.1M142.1M
Total assets69.0M74.6M96.4M104.7M73.6M97.5M179.3M
Accounts payable2.20M321.0K939.0K585.0K839.0K242.0K179.0K
Current liabilities34.2M25.5M38.7M11.2M16.6M16.8M19.8M
Long-term debt10.1M12.9M15.8M0
Total debt58.9M52.5M16.7M1.67M6.16M10.7M
Total liabilities45.9M64.6M63.6M24.0M16.6M18.4M25.8M
Shareholders' equity23.1M10.1M32.7M80.7M57.0M79.1M153.5M
Shares outstanding40.6M22.8M54.9M54.2M52.3M49.3M48.7M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-36.9M-40.3M-46.2M8.12M-72.0M-57.2M-97.0M
Capital spending-378.0K-1.07M-1.75M-745.0K-1.58M-1.85M-1.54M
Free cash flow-37.3M-40.9M-47.9M7.37M-73.5M-59.0M-98.5M
Cash from investing-1.68M-2.93M-680.0K4.26M28.1M46.2M
Cash from financing31.7M50.3M24.9M46.6M-2.42M11.0M
Change in cash1.15M-10.3M1.20M32.4M-21.1M-31.4M-39.7M

Open Financials

Cap table

Built by 6ix from iXensor Co., Ltd.’s releases

Common shares
42,051,552
Fully diluted
42,051,552

Fully diluted

LineShares
Common shares42,051,552

Share count over time

CountShares
Nov 22, 202642,051,552

Open Cap table

Shareholders

HolderSharesOf the companyAs of
遠瞻管理顧問有限公司6.21M15.3%Oct 31, 2026
陳彥宇650K1.6%Oct 31, 2026
黃舒蘭220K0.54%Oct 31, 2026
陳冠廷135K0.33%Oct 31, 2026
趙品尊105K0.26%Oct 31, 2026
陳翰林83,0000.20%Oct 31, 2026
邱惲翔00.00%Oct 31, 2026
Peter Fitzgerald00.00%Oct 31, 2026
賴怡文00.00%Oct 31, 2026
蘇志淵00.00%Oct 31, 2026
All 12 holders
HolderSharesOf the companyAs of
郭書齊00.00%Oct 31, 2026
鍾志杰00.00%Oct 31, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Carson ChenChairman & CEO · Since at least Nov 5, 2026
Peter FitzgeraldDirector & Chief Medical Advisor · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about iXensor Co., Ltd.